John R Moore's Net Worth
$2.92 Million
Who is John R Moore?
John R Moore has an estimated net worth of $2.92 Million. This is based on reported shares across multiple companies, which include Nivalis Therapeutics, Inc., Edgewise Therapeutics, Inc., and ARRAY BIOPHARMA INC.
SEC CIK
John R Moore's CIK is 0001191702
Past Insider Trading and Trends
2022 was John R Moore's most active year for acquiring shares with 25 total transactions. John R Moore's most active month to acquire stocks was the month of May. 2022 was John R Moore's most active year for disposing of shares, totalling 44 transactions. John R Moore's most active month to dispose stocks was the month of May. 2015 saw John R Moore paying a total of $182,331.76 for 218,681 shares, this is the most they've acquired in one year. In 2024 John R Moore cashed out on 66,834 shares for a total of $633,793.42, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nivalis Therapeutics, Inc. (ALPN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Edgewise Therapeutics, Inc. (EWTX) Snapshot price: $17.52
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
∞
| 3.25K |
$18.91 | -$36,987.96 | 3.25K |
May 1 - May 2
| |||
Form 4
|
—
|
0
|
$10.97 | -$539,223.91 |
0
|
Feb 7 - Feb 9
| |||
Form 4
| -100.00% | -8.50K |
$10.50 | -$89,218.50 |
0
|
Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
| +101.75% | 3.31K |
$8.90 | -$16,892.60 | 6.57K |
May 1 - May 2
| |||
Form 4
|
—
|
0
|
$5.85 | -$37,025.97 | 3K |
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
$6.42 | -$42,468.82 | 3K |
Scheduled
|
Sep 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 4
|
—
|
0
|
$5.33 | -$73,595.98 | 3K |
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$4.85 | -$64,931.04 | 3K |
Scheduled
|
Jul 5 - Jul 6
| ||
Form 4
|
—
|
0
|
$4.26 | -$349,315.58 | 3K |
Scheduled
|
Jun 16 - Jun 21
| ||
Form 4
|
—
|
0
|
$3.41 | -$141,012.30 | 3K |
Scheduled
|
Jun 13 - Jun 15
| ||
Form 4
|
—
|
0
|
$3.58 | -$156,491.10 | 3K |
Scheduled
|
Jun 8 - Jun 10
| ||
Form 4
|
—
|
0
|
$3.88 | -$225,644.08 | 3K |
Scheduled
|
Jun 3 - Jun 7
| ||
Form 4
| -78.26% | -10.80K |
$7.42 | -$80,145.72 | 3K |
Scheduled
|
May 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +77.56% | 5.4K |
$0.71 | $3,834.00 | 12.36K |
Jan 21
| |||
Form 4
| +345.71% | 5.4K |
$0.71 | $3,834.00 | 6.96K |
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARRAY BIOPHARMA INC No price found
VP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -13.71% | -6.37K |
$8.94 | -$56,947.80 | 40.1K |
Apr 1
| |||
Form 4
| +5.81% | 2.31K |
$8.94 | -$39,407.52 | 42.06K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
| -5.93% | -2.50K |
$3.00 | -$7,515.00 | 39.75K |
Apr 1
| |||
Form 4
| +174.69% | 26.88K |
—
|
—
| 42.26K |
Apr 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 15.36K |
$7.96 | $122,297.44 | 15.36K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| -99.83% | -11.67K |
$5.79 | -$67,546.14 | 20 |
Scheduled
|
Nov 29
| ||
Form 4
| -1.68% | -200.00 |
$5.79 | -$1,158.00 | 11.69K |
Scheduled
|
Nov 13
| ||
Form 4
| -28.59% | -4.76K |
$5.00 | -$318,398.61 | 11.89K |
Scheduled
|
Aug 1 - Aug 2
| ||
Form 4
| +40.04% | 4.76K |
$4.87 | -$953.75 | 16.64K |
Scheduled
|
Jul 23 - Jul 25
| ||
Form 4
|
—
|
0
|
$4.63 | -$75,600.00 | 11.89K |
Scheduled
|
Apr 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
| -70.60% | -28.55K |
$5.69 | -$162,312.53 | 11.89K |
Scheduled
|
Oct 8
| ||
Form 4
| +45.38% | 11.89K |
—
|
—
| 38.08K |
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
∞
| 28.55K |
—
|
—
| 28.55K |
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| -100.00% | -356.00 |
$3.30 | -$1,174.80 |
0
|
Scheduled
|
Apr 5
| ||
Form 4
| -89.26% | -2.96K |
$3.30 | -$9,764.70 | 356 |
Scheduled
|
Jan 10 - Jan 11
| ||
Form 4
| -100.00% | -24.04K |
$3.25 | -$78,126.75 |
0
|
Scheduled
|
Jan 6
| ||
Form 4
| +28.32% | 6.04K |
$3.29 | -$66,020.43 | 27.35K |
Scheduled
|
Oct 4 - Oct 5
| ||
Form 4
| -23.95% | -6.32K |
$3.25 | -$20,536.75 | 20.07K |
Scheduled
|
Aug 2 - Aug 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +337.35% | 21.32K |
—
|
—
| 27.64K |
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
| -100.00% | -2.40K |
$9.21 | -$221,695.69 |
0
|
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
| -66.43% | -4.46K |
$9.38 | -$41,797.28 | 2.25K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1 - Aug 1
| |||
| No matching records found | |||||||||